NNNN CIK: 1982708

Anbio Biotechnology

  • Germany
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
15.7
FY24:
18.5
FY25:
30.2
(positive)
Change from FY23 to FY25
millions USD
FY23:
0.06
FY24:
0.39
FY25:
0
Total assets
Change from FY23 to FY25
millions USD
FY23:
15.8
FY24:
18.9
FY25:
30.2

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
0.99
FY24:
1.73
FY25:
0.09
(negative)
millions USD
FY23:
0
FY24:
0
FY25:
0
(positive)
Change from FY23 to FY25
millions USD
FY23:
14.8
FY24:
17.2
FY25:
30.2
Total liabilities & equity
Change from FY23 to FY25
millions USD
FY23:
15.8
FY24:
18.9
FY25:
30.2

All amounts in millions USD Data source:SEC EDGAR